cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
about
Postoperative adjuvant chemotherapy in rectal cancer operated for cureCurrent treatment of rectal cancer adapted to the individual patientRestaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study.Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.Patterns of local recurrence in rectal cancer after a multidisciplinary approach.Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesMagnetic resonance imaging (MRI) in rectal cancer: a comprehensive reviewNeoadjuvant treatment in rectal cancer: actual status.Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaImplications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.Treatment of locally advanced rectal cancer: controversies and questions.ACR appropriateness criteria® resectable rectal cancerComparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.Two-marker protein profile predicts poor prognosis in patients with early rectal cancerA predictive nomogram improved diagnostic accuracy and interobserver agreement of perirectal lymph nodes metastases in rectal cancer.Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.Local recurrence after curative resection for rectal carcinoma: The role of surgical resection.Laparoscopic Low Anterior Resection and Eversion Technique Combined With a Nondog Ear Anastomosis for Mid- and Distal Rectal Neoplasms: A Preliminary and Feasibility Study.Radiation therapy for rectal cancer: current status and future directions.Long-term outcomes of surgery alone versus surgery following preoperative chemoradiotherapy for early T3 rectal cancer: A propensity score analysis.Rectal cancer radiotherapy: towards European consensus.Local staging of rectal cancer: a review of imaging.Surgical oncology issues in locally advanced rectal cancer.Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies.Preoperative versus postoperative radiotherapy for rectal cancer in a decision analysis and outcome prediction model.Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?Optimal therapy for resectable rectal cancer.Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer?Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.Accomplishments in 2007 in the adjuvant treatment of rectal cancer.Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.The right study design is needed to find out which patients benefit from preoperative chemoradiotherapy for intermediate staged rectal cancer.Selective use of preoperative chemoradiotherapy for T3 rectal cancer can be justified: analysis of local recurrence.The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?
P2860
Q24201072-7285F25B-C8D6-43CF-BAD7-082DE9EC028EQ26824553-34853C72-F9F7-4DA3-97CD-A91708E8BDABQ30426570-1DDFCA68-001D-4CEE-B05C-35C7ADEC1488Q34437609-7D4F84EE-4A12-496A-9F50-E19AF471B907Q34633373-47A5E628-79EE-496E-B63E-9A0192BCA474Q34771979-D660831C-75A0-4647-B350-15CF968D4F7DQ34898391-E25579FF-C5A0-484C-A825-D6B589204DABQ35569457-AC1CBE19-B02E-4C00-B8BB-581EA7259D28Q35675792-C82A47B9-BFD4-4B32-871C-0F16D4A17FB2Q35687452-E2D988B8-D0BF-4F90-89E4-3699ACD1EB58Q35698262-CD6FA24B-F4CA-4361-A77B-FB399B952C76Q35793914-33836645-0D89-4577-93BC-C2129AD74BA4Q36260173-A4BFF253-B2D9-40FF-A0E6-D3B009863D6CQ36351882-B5A9A6BD-FBFD-4C6B-A275-4E75E8C615DCQ36371152-968CF28C-3C78-4EA4-A4E1-26EF5978C3C4Q36540452-01F0764C-C235-4051-BFD0-53CA35C846FAQ36977547-716128F8-C6EA-442C-B8E2-869B8A925F83Q37046706-5E6FB633-A3E6-4351-A69E-A217D037DEFFQ37077330-45A585AC-D0DE-467C-B19E-4F8CD2B65EB2Q37132742-5B0CE048-3DED-4268-B079-B9FA2C1D5C88Q37327881-9049ABB5-1F90-4D2C-A7A6-16A82E87BFE6Q37328386-DC08C323-24B4-4BF5-89BC-9083450EBE7AQ37654670-AB3F5801-91A9-456C-89BA-96F8534344FAQ37727236-BBA248D1-5B7D-4985-BC6D-F18BADDA3DF5Q37789029-035FDD3A-22B8-46F4-A0C6-996F5D10F2E9Q37867593-D9EAF4FD-C511-4752-802A-D1F7808FBDFDQ37980472-DA680FE3-639A-4C77-BCA6-DA6BAF4F7CABQ38001344-01305AF8-2EAF-4950-AF71-37AEF727D7BDQ38024278-0FBA76A5-180C-40E3-936C-D5C9FC100463Q38064749-A8B9FBC1-3073-4E4A-BEFD-5E9EFFA36535Q38134007-1E3F8FD9-78D2-4C83-80A1-FB9AD91BA25BQ38664897-4AFB979B-1B4B-44CF-A1E1-0815E0B33FB9Q39413499-7ECE1B43-3233-467F-B7CA-B512F7290F74Q39994760-4026B029-F9AE-4685-B829-2365365E841DQ41547205-CAF59F37-1C5C-412F-9138-F1D43C509FAFQ41997655-0772FA91-EBC7-45AB-B13F-0D758013612EQ43406325-230A58AB-F154-4A2E-B0B7-6D5BA15D6A2EQ43463277-0F7BF706-9AE7-408A-A05F-B4C8C563C560Q44226585-80D42C84-E993-4173-9465-2FDC42860493Q45899555-3D89C7CC-BD98-4734-A8F3-9649D4DB469B
P2860
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@en
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@nl
type
label
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@en
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@nl
prefLabel
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@en
cT3N0 rectal cancer: potential ...... hemoradiotherapy is warranted.
@nl
P2093
P50
P356
P1476
cT3N0 rectal cancer: potential ...... chemoradiotherapy is warranted
@en
P2093
Bruce D Minsky
Claudio Coco
Donato Nitti
Elyn R Riedel
José G Guillem
José L Hernandez-Lizoain
Juan A Díaz-González
Miguel A Rodriguez-Bigas
Rebecca Leon
Seung-Yong Jeong
P304
P356
10.1200/JCO.2007.13.5434
P407
P577
2008-01-01T00:00:00Z